Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT05591040
Recruiting Not applicable

Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia

NCT05591040 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2022-10-30
Last updated
2026-03-27

Condition(s) studied

DysphagiaRehabilitationStroke

Investigational drug(s) / intervention(s)

BiofeedbackConventional

Biofeedback: Each participant will attend 5 sessions per week for a total duration of 4 weeks. The duration of each session will take 1 hour, including bio-feedback preparation. At the beginning of the bio-feedback session, two surface electrodes will be applied to the mylohyoid muscle. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, specific task for timing and coordination, Masako maneuver. The experimental group will perform this training for 45 minutes, plus they will receive a verbal feedback from the speech and language therapist in relation to the efficacy of the performance.

Conventional: Each participant will attend 5 sessions per week for a total duration of 4 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, specific task for timing and coordination, Masako maneuver. The control group will perform this training for 45 minutes, with a verbal feedback from the speech and language therapist in relation to the efficacy of the performance.

Study summary

The aim of the study is to evaluate whether the effect of biofeedback treatment is more effective than a control treatment in the recovery of dysphagia.

This study will be a multicentric randomized, single-blind controlled study. The investigators intend to recruit 100 patients who have suffered a stroke and have dysphagia. Fifty patients will undergo training with bio-feedback (experimental group) and the other fifty patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). Our hypothesis, based on the results obtained in some previous studies, is that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength, timing, coordination and efficacy of the swallowing act.

Eligibility

Sex
ALL
Min age
18 Years
Max age
89 Years
Healthy volunteers
No
Inclusion Criteria: * first stroke injury * onset from more than six weeks * presence of dysphagia * good comprehension ( not below PT 53 in Token Test) * good eyesight and hearing, or adequately corrected Exclusion Criteria: * All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area); * Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration; * Serious dystonia or unintentional movements * presence of disorders of consciousness; * encephalopathy due to multiple infarcts; * inability to sustain the experimental treatment; * other neurological diseases (for example Parkinson disease)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sara Nordio Venice-Lido Italy Recruiting

More IRCCS San Camillo, Venezia, Italy trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05591040 on ClinicalTrials.gov ↗ ← All trials in Italy